Some interesting Findings from ASTRO - Advanced Prostate...

Advanced Prostate Cancer

23,807 members29,091 posts

Some interesting Findings from ASTRO

Mgtd profile image
Mgtd
4 Replies

I believe Tall Allen reported on the first one but the others may interest you also.

urologytimes.com/clinical/p...

Written by
Mgtd profile image
Mgtd
To view profiles and participate in discussions please or .
4 Replies
addicted2cycling profile image
addicted2cycling

new is OLDER stuff????

pubmed.ncbi.nlm.nih.gov/176...

Mascouche profile image
Mascouche

Here is an excerpt of Short-term ADT plus radiotherapy improves disease-free survival in higher-risk prostate cancer:

“Given the adverse effects of ADT, it is commonly underused in real-world settings, with men receiving considerably shorter durations of ADT than indicated,” Kishan and colleagues wrote.

In GETUG 14, Demogeot and colleagues randomized 376 patients with intermediate to high prostate cancer risk to either short-term ADT plus radiotherapy (n = 179) or lone radiotherapy (n = 191). Both treatment arms received an 80 Gy dose; ADT was monthly triptorelin and daily flutamide over 4 months, starting 2 months before irradiation.

The team sought a primary endpoint of disease-free survival, and secondary endpoints including overall survival, biochemical failure, metastasis failure, toxicity, and patient-reported quality of life.

Over a median follow-up period of 84 months, investigators observed a 5-year disease-free survival of 84% among the short-term ADT plus radiotherapy arm, versus 76% among the radiotherapy arm—indicating a 36% reduced risk (hazard ratio [HR], 0.64; 95% CI, 0.43 – 0.89; P = .02). The addition of short-term ADT was also associated with significantly reduced biochemical failure (HR, 0.45; P = .001) and metastasis failure (HR, 0.50; P = .09). However, overall survival was not significantly improved with the combination therapy versus radiotherapy (HR, 1.22; P = .54).

Mascouche profile image
Mascouche in reply toMascouche

So they are saying 2 months of ADT before RT and another 2 months after RT. Much smaller window than the 18 to 36 months of ADT from earlier recommendations.

However they seem to compare 4 months of ADT plus 80 Gy of RT vs 80 Gy of RT alone. I don't see a comparison between 4 months of ADT plus 80 Gy of RT vs 18 months of ADT plus 80 Gy of RT.

Derf4223 profile image
Derf4223

Very small study. For localized PCa patients getting RT.

Not what you're looking for?

You may also like...

Positive effect of diet on the whole PCa / APCa spectrum

https://www.urologytimes.com/view/plant-based-diet-demonstrates-benefits-along-spectrum-of-prostate-
Derf4223 profile image

Using Provenge before AR inhibitors.

https://www.urologytimes.com/view/sipuleucel-t-boosts-survival-versus-abiraterone-or-enzalutamide-al
dhccpa profile image

2020 AUA conference studies

https://www.urologytimes.com/clinical/prostate-cancer?page=9 You'll find something on almost any...
maley2711 profile image

HIFI versus RP Results

https://www.urologytimes.com/view/published-data-show-noninferior-treatment-free-survival-with-hifu-
Mgtd profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.